2Foley RN,Collins AJ.End-stage renal disease in the United States:an update from the United States Renal Data System.J Am Soc Nephrol,2007,18(10):2644-2648.
3Fathi R,Isbel N,Haluska B,et al.Correlates of subclinical left vent ricular dysfunction in ESRD.Am J Kidney Dis,2003,41(5):1016-1025.
4Mitsnefes MM,Daniels SR,Schwartz SM,et al.Changes in left vent ricular mass in children and adolescents during chronic dialysis.Pediatr Nephrol,2001,16(4):318-323.
5Patel RK,Oliver S,Mark PB,et al.Determinants of Left Ventricular Mass and Hypertrophyin Hemodialysis Patients Assessed by Cardiac Magnetic ResonanceImaging.J Am Soc Nephrol,2009,4(9):1477-1483.
6Wald R,Tentori F,Tighiouart H,et al.Impact of the KidneyDisease outcomes Quality Initiative (KDOQI) Clinical prac-tice Guidelines for Bone Metabolism and Disease in a large dialysis network.Am I Kidney Dis,2007,49(2):257-266.
7Takeda A,Toda T,Iwamoto H,et al.Long-Term Evolution and Changing Associations of Left Ventricular Hypertrophy after Starting Hemodialysis.Nephron Clin Pract,2008,110(1):c126.
8Achinger SG,Ayus JC.Left Ventricular Hypertrophy:Is Hyperphosphatemia among Dialysis Patients a Risk Factor.J Am Soc Nephrol,2006,17(12 Suppl 3):S255-S261.
9Koc Y,Unsal A,Kayabasi H.Impact of volume status on blood pressure and left ventricle structure in patients undergoing chronic hemodialysis J.Ren Fail,2011,33(4):377-381.
10Hambali Z,Ahmad Z,Arab S,et al.Oxidative stress and its association with cardiovascular disease in chronic renal failure patients.Indian J Nephrol,2011,21(1):21-25.
